Avacta Group Share News (AVCT)
AVCT Share
AVCT Share
AVCT Share
AVCT Share
AVCT
AVCT Share
AVCT Level 2
AVCT Live
AVCT Broker
AVCT Directors
AVCT Financial
AVCT
AVCT Short
AVCT
Last checked at -
AIM-quoted diagnostic tests and testing equipment supplier Avacta has proposed to acquire diagnostics firm Aptuscan for £1.48m using funds raised from a placing. The firm today announced the placing of up to 1,026m ordinary shares at a price of 0.5 per share to raise £5.3m. Once completed, the £1.4
Read moreAIM-quoted diagnostic tests and testing equipment supplier Avacta saw shares fall lower despite announcing that it traded in line with expectations in the second half. The firm, which develops diagnostic tests for both animal and human healthcare, said that underlying revenues improved in the six m
Read moreAIM-quoted diagnostic tests and testing equipment supplier Avacta says that revenue will be lower than expected in the six months to January 2011. Avacta says that there was "solid underlying revenue growth" in the period but a slightly bigger loss than forecast will be made at the interim stage.
Read moreTowerBrook Capital Partners has decided not to bid for nursing homes operator Southern Cross Healthcare. TowerBrook made what was described as "a highly preliminary proposal" in August. Southern Cross says that other parties have approached it and discussions are continuing. Full year figures will b
Read moreBiomass power group Kedco has agreed a £9.9m project finance facility with Ulster Bank Group, a subsidiary of the Royal Bank of Scotland, to provide secured debt facilities for its biomass electricity and heat generating plant in Newry, Northern Ireland. The facilities comprise a term loan as well a
Read moreAustralian miner Norseman Gold suffered a drop in production during the first quarter to 12,229 ounces from 14,469 ounces in the three months to June following a fatality at the OK Decline in August. The accident caused a three week shutdown at the mine and meant output was well below target but i
Read moreHay fever treatment specialist Allergy Therapeutics posted an operating profit for the year to June of £1.5m (2009: loss £5.1m) and cut losses to £116,000 from £11.4m. "On the regulatory front, the submission in March 2009 of Pollinex Quattro Grass, our ultra-short course four injection grass alle
Read moreDow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps ROCKHOPPER EXPLORATION PLC (RKH.LN), a Falkland Islands-focused oil and gas explorer, said Tuesday Executive Chairman Pierre Jungels bought another 23,35
Read moreDow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps ROCKHOPPER EXPLORATION PLC (RKH.LN), a Falkland Islands-focused oil and gas explorer, said Tuesday Executive Chairman Pierre Jungels bought another 23,35
Read moreLONDON (Dow Jones)--Drug research and analysis company Avacta Group PLC (AVCT.LN) Tuesday said it raised GBP1.38 million in a share sale to fund sales of its Optim protein analyzer and animal diagnostic system Midas. Avacta said it will use the money to improve its manufacturing facilities and h
Read moreCommodity investor Commoditrade narrowed full-year losses to $14.7m from $40.9m in 2008, although revenue sank to $20.1m from $31.1m despite an improvement in the second half. "As a result of the significant changes made during the last year, Commoditrade is in a much stronger position to grow reve
Read moreSpeciality pharmaceutical company ProStrakan's New Drug Application (NDA) filing for Abstral has been accepted for review by the US Food and Drug Administration (FDA). Subject to successful completion of the US approval process, the Scottish firm plans to launch Abstral, which helps ease pain for
Read more
Last checked at